Quote | Super Quote
47962 HS-HSI @L 2303B (X)
RT Nominal unchange 0.000 (0.000%)

26/10/2021 11:40

Ali Health (00241) expects to record interim loss

[ET Net News Agency, 26 October 2021] Alibaba Health Information Technology Limited
(00241) said the group expects to record a net loss of not more than RMB320 million for
the six months ended 30 September 2021 (6M FY2021) as compared with the net profit of
approximately RMB279 million for the corresponding period in 2020.
The group's net loss for 6M FY2021 was mainly attributable to (i) the increase in the
deployment of the group's resources to invest in a series of innovative business areas
such as the "Dr. Deer" APP and health insurance; (ii) the group's continuous investment in
drug supply chain capabilities, including drug storage and logistics, as well as
operational service improvements in the group's pharmaceutical direct sales business,
customer experiences in prescription refills and the research and development of the
skills for prescription drug regulatory compliance and safety; (iii) the group's
increasing investment in building the brand awareness of Tmall's Pharmaceutical Platform
and Alibaba Health Pharmacy; (iv) decrease in operating margin of the group's direct sales
business as the group increased its market share of online B2C drug sales, accelerated
business deployment of prescription drug sales business and increased the deployment of
corresponding market resources; partially offset by the increase in unrealised gain on
changes in fair values of investment. (RC)

Remark: Real time quote last updated: 03/12/2021 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.